Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis

被引:87
|
作者
Schaefer, Michael [1 ]
Sahin, Tamay [1 ]
Berstecher, Benjamin [1 ]
机构
[1] Med Sch Berlin, Calandrellistr, Berlin, Germany
来源
PLOS ONE | 2018年 / 13卷 / 03期
关键词
NONCONSCIOUS ACTIVATION; CLINICAL-TRIALS; RESPONSES; PAIN;
D O I
10.1371/journal.pone.0192758
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Several studies demonstrated that placebo treatment may have a significant impact on many different symptoms. While in the traditional view concealment of the placebo is essential, recent studies report intriguing evidence that placebos may work even without deception. For example, it has been demonstrated that open-label placebos can improve symptoms in allergic rhinitis. However, the mechanisms of how placebos without concealment work remain unknown. Trial design In order to examine expectancy effects we conducted a randomized controlled trial (N = 46), in which patients with allergic symptoms received either placebos without deception or no pills at all. In half of those patients we induced positive expectations about the placebo effect. After two weeks we tested whether symptoms and quality of life had changed. Results Results revealed that open-label placebos improved allergic symptoms more than the control group. Inducing positive expectations had no effects on the improvement of allergic symptoms (the primary and more objective outcome), but on mental sum scores of the quality of life questionnaire. Conclusions Placebos without deception can improve symptoms in allergic rhinitis. Positive expectations do not contribute to the efficacy of open-label placebos, but seem to have an effect on more global and subjective well-being (mental or emotional quality of life).
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Open-Label Placebos Improve Symptoms in Allergic Rhinitis: A Randomized Controlled Trial
    Schaefer, Michael
    Harke, Rebecca
    Denke, Claudia
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2016, 85 (06) : 373 - 374
  • [2] Providing open-label placebos remotely-A randomized controlled trial in allergic rhinitis
    Kube, Tobias
    Hofmann, Verena E.
    Glombiewski, Julia A.
    Kirsch, Irving
    PLOS ONE, 2021, 16 (03):
  • [3] Rethinking placebo: Exploring the effectiveness of open-label placebos
    Babel, Przemyslaw
    EUROPEAN JOURNAL OF PAIN, 2024, 28 (03) : 357 - 358
  • [4] Open-label Placebos for Wound Healing: A Randomized Controlled Trial
    Mathur, Ashwin
    Jarrett, Paul
    Broadbent, Elizabeth
    Petrie, Keith J.
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 (10) : 902 - 908
  • [5] A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis
    Michael Schaefer
    Kurt Zimmermann
    Paul Enck
    Scientific Reports, 13
  • [6] A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis
    Schaefer, Michael
    Zimmermann, Kurt
    Enck, Paul
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] The effect of open-label placebo on allergic rhinitis symptoms: A systematic review and meta-analysis of randomized controlled trials
    Albazee, Ebraheem
    Alharran, Abdullah M.
    Alzayed, Mooza M.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2025, 15 (01) : 81 - 85
  • [8] Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial
    Kelley, John M.
    Kaptchuk, Ted J.
    Cusin, Cristina
    Lipkin, Samuel
    Fava, Maurizio
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2012, 81 (05) : 312 - 314
  • [9] Open-label placebos for menopausal hot flushes: a randomized controlled trial
    Pan, Yiqi
    Meister, Ramona
    Loewe, Bernd
    Kaptchuk, Ted J.
    Buhling, Kai J.
    Nestoriuc, Yvonne
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [10] Open-label placebos for menopausal hot flushes: a randomized controlled trial
    Yiqi Pan
    Ramona Meister
    Bernd Löwe
    Ted J. Kaptchuk
    Kai J. Buhling
    Yvonne Nestoriuc
    Scientific Reports, 10